Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Cash Flow Quality Index
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow Quality Index of 7.00x as of September 2025. Operating cash flow of CN¥1.25 Billion exceeds net income of CN¥178.84 Million, indicating high earnings quality where cash backs reported profits. Explore 600866 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Starlake Bioscience Co Inc Zhaoqing Guangdong across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Starlake Bioscience Co Inc Zhaoqing Guan reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year earnings quality comparison for Starlake Bioscience Co Inc Zhaoqing Guangdong. For live market cap and the full company financial profile, see 600866 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.32x | CN¥1.29 Billion | CN¥978.89 Million | ▼ -47.7% |
| 2024 | 2.52x | CN¥2.40 Billion | CN¥949.81 Million | ▼ -15.5% |
| 2023 | 2.99x | CN¥2.03 Billion | CN¥677.95 Million | ▲ +112.7% |
| 2022 | 1.41x | CN¥1.66 Billion | CN¥1.18 Billion | ▼ -22.3% |
| 2021 | 1.81x | CN¥192.63 Million | CN¥106.47 Million | ▲ +7.6% |
| 2020 | 1.68x | CN¥249.99 Million | CN¥148.71 Million | ▲ +17.9% |
| 2019 | 1.43x | CN¥213.17 Million | CN¥149.55 Million | ▲ +18.9% |
| 2018 | 1.20x | CN¥50.69 Million | CN¥42.28 Million | ▼ -29.2% |
| 2016 | 1.69x | CN¥41.17 Million | CN¥24.31 Million | ▲ +127.2% |
| 2013 | -6.23x | CN¥-28.16 Million | CN¥4.52 Million | ▼ -853.0% |
| 2011 | 0.83x | CN¥65.88 Million | CN¥79.63 Million | ▲ +123.5% |
| 2010 | 0.37x | CN¥104.63 Million | CN¥282.63 Million | ▼ -73.9% |
| 2009 | 1.42x | CN¥316.73 Million | CN¥223.68 Million | ▼ -73.2% |
| 2008 | 5.29x | CN¥148.93 Million | CN¥28.16 Million | ▲ +159.3% |
| 2006 | 2.04x | CN¥35.14 Million | CN¥17.23 Million | ▼ -43.5% |
| 2005 | 3.61x | CN¥46.83 Million | CN¥12.96 Million | ▲ +382.3% |
| 2004 | 0.75x | CN¥29.05 Million | CN¥38.79 Million | ▼ -64.3% |
| 2003 | 2.10x | CN¥149.70 Million | CN¥71.38 Million | ▼ -9.2% |
| 2002 | 2.31x | CN¥183.18 Million | CN¥79.30 Million | ▲ +158.8% |
| 2001 | 0.89x | CN¥60.82 Million | CN¥68.14 Million | ▼ -17.3% |
| 2000 | 1.08x | CN¥93.41 Million | CN¥86.50 Million | ▲ +43.9% |
| 1999 | 0.75x | CN¥52.97 Million | CN¥70.60 Million | ▼ -26.1% |
| 1998 | 1.01x | CN¥71.14 Million | CN¥70.09 Million | — |